Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2024-01-11 00:00:00 ET · period of report 2024-01-08 · accession 0001048477-24-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-01-11 | 2024-01-09+ | BMRN | BIENAIME JEAN JACQUES | Dir | M - OptEx | $63.10 | +20.0K | 435.2K | +5% | +$1.26M |
| D | 2024-01-11 | 2024-01-08 | BMRN | BIENAIME JEAN JACQUES | Dir | L - Small Acq | $99.05 | +50 | 425.2K | +0.0% | +$4,952 |
| DM | 2024-01-11 | 2024-01-09+ | BMRN | BIENAIME JEAN JACQUES | Dir | S - Sale+OE | $97.28 | -20.0K | 425.2K | -4% | -$1.95M |
| DM | 2024-01-11 | 2024-01-09+ | BMRN | BIENAIME JEAN JACQUES | Dir | M - OptEx | $0.00 | -20.0K | 161.0K | -11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-10 | M | A | 10,000 | $63.10 | 435,162 | D | — | — | (F2) Trade made pursuant to a 10b5-1 plan executed on August 7, 2023. |
| 2 | Common | Common Stock | 2024-01-08 | L | A | 50 | $99.05 | 425,162 | D | — | — | (F1) The sale reported in this Form 4 was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 50 shares, with the reporting person's sale of shares at a price of $98.19 on January 9, 2024. The reporting person has agreed to pay to the Issuer the full amount of the profit realized by the reporting person in connection with the short-swing transaction, less transaction costs. |
| 3 | Common | Common Stock | 2024-01-09 | M | A | 10,000 | $63.10 | 435,162 | D | — | — | (F2) Trade made pursuant to a 10b5-1 plan executed on August 7, 2023. |
| 4 | Common | Common Stock | 2024-01-10 | S | D | 10,000 | $96.38 | 425,162 | D | — | — | (F2) Trade made pursuant to a 10b5-1 plan executed on August 7, 2023. |
| 5 | Common | Common Stock | 2024-01-09 | S | D | 10,000 | $98.19 | 425,162 | D | — | — | (F2) Trade made pursuant to a 10b5-1 plan executed on August 7, 2023. |
| 6 | Derivative | Stock Option (Right to Buy Common Stock) | 2024-01-09 | M | D | 10,000 | $0.00 | 171,000 | D | $63.10 · 2014-12-04 to 2024-06-03 | 10,000 Common Stock | (F3) Reflects the number of options outstanding after the transactions from this specific stock option grant. |
| 7 | Derivative | Stock Option (Right to Buy Common Stock) | 2024-01-10 | M | D | 10,000 | $0.00 | 161,000 | D | $63.10 · 2014-12-04 to 2024-06-03 | 10,000 Common Stock | (F3) Reflects the number of options outstanding after the transactions from this specific stock option grant. |